Eli Lilly
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
CEODavid A. Ricks
CEODavid A. Ricks
Employees47,000
Employees47,000
HeadquartersIndianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded1876
Founded1876
Employees47,000
Employees47,000
LLY Key Statistics
Market cap732.45B
Market cap732.45B
Price-Earnings ratio64.67
Price-Earnings ratio64.67
Dividend yield0.72%
Dividend yield0.72%
Average volume2.88M
Average volume2.88M
High today$781.15
High today$781.15
Low today$762.40
Low today$762.40
Open price$779.68
Open price$779.68
Volume2.58M
Volume2.58M
52 Week high$972.53
52 Week high$972.53
52 Week low$677.09
52 Week low$677.09
LLY News
Simply Wall St 21m
Eli Lilly and Company is a favorite amongst institutional investors who own 89%Advertisement Key Insights Significantly high institutional ownership implies Eli Lilly's stock price is sensitive to their trading actions A total of 10 inv...
TipRanks 1h
Positive Outlook for Eli Lilly & Co Driven by Strong Product Performance and International GrowthMohit Bansal, an analyst from Wells Fargo, maintained the Buy rating on Eli Lilly & Co. The associated price target remains the same with $1,100.00. Don’t Miss...
TipRanks 16h
Eli Lilly Lowers Cost of Weight-Loss Drug as Insurance Coverage Remains ElusiveEli Lilly (LLY) continues to lower prices for its popular weight-loss drug Zepbound. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at...
Analyst ratings
83%
of 30 ratingsBuy
83.3%
Hold
10%
Sell
6.7%
More LLY News
TipRanks 4d
Eli Lilly and Regeneron: Exploring New Frontiers in Obesity TreatmentEli Lilly And Company ((LLY)), Regeneron Pharmaceuticals ((REGN)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Tak...
People also own
Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.